Abstract: The invention relates to compositions and methods for targeting sequence modifications in one or more genes of a related family of genes using enhanced homologous recombination techniques. These techniques may be used to create animal or plant models of disease as well as to identify new targets for drug or pathogen screening.
Type:
Application
Filed:
February 24, 2003
Publication date:
May 13, 2004
Applicant:
Pangene Corporation
Inventors:
Sushma Pati, David A. Zarling, Christopher W. Lehman, Hong Zeng
Abstract: Methods and compositions are providing for modulating cellular activity. In the subject methods, target cells are contacted with both a BER inhibitor and a sensitizing agent, e.g., either a radiosensitizing agent and/or a chemotherapeutic agent, where the cells may optionally be contacted with a DSBR inhibitor, such as a RAD inhibitor, e.g., a RAD51 inhibitor. Also provided are pharmaceutical preparations, as well as kits thereof, that find use in practicing the subject methods.
Type:
Application
Filed:
March 20, 2003
Publication date:
December 11, 2003
Applicant:
Pangene Corporation
Inventors:
David A. Zarling, Gurucharan Reddy, Pietro Taverna
Abstract: Provided herein are methods for inhibiting cell proliferation in an individual comprising administering to the individual a composition comprising a Rad51 inhibitor. Also provided herein is a method for inhibiting the growth of a cell comprising administering to said cell a composition comprising a Rad51 inhibitor. Such methods can further include the step of providing radiation or DNA damaging agents after administration of said Rad51 inhibitor. Also described herein are methods which are performed in vivo and/or on cancerous cells.
Type:
Grant
Filed:
December 6, 1999
Date of Patent:
June 10, 2003
Assignee:
Pangene Corporation
Inventors:
Hong Zeng, Gurucharan Reddy, Anne Vallerga, David A. Zarling
Abstract: The invention relates to compositions and methods for targeting sequence modifications in one or more genes of a related family of genes using enhanced homologous recombination techniques. These techniques may be used to create animal or plant models of disease as well as to identify new targets for drug or pathogen screening.
Type:
Grant
Filed:
December 11, 1998
Date of Patent:
February 25, 2003
Assignee:
Pangene Corporation
Inventors:
Sushma Pati, David A. Zarling, Hong Zeng
Abstract: Nucleoproteins comprising overlapping homologous DNA sequences coated with a recombinase are employed for introduction into cells to produce double D-loop structures. The sequences may be modified with various moieties which result in modification of DNA. Formation of the D-loops results in inhibition of replication and transcription, where the moieties can be employed for permanent scission or modification of the DNA. The methods and compositions can be used for investigating physiological processes, for producing animal models, and for inhibition of an undesirable phenotype in vivo.